Records containing: Stage IIIB Breast Cancer

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2023-04-20
Accelerated, Hypofractionated Post-Mastectomy Radiation Therapy in Women With Breast Cancer: A Phase II Trial
CLINICAL_TRIALS study record update · 2023-03-29
A Phase 2 Trial of Liposomal Doxorubicin and Carboplatin in Patients With ER, PR, HER2 Negative Breast Cancer (TNBC)
CLINICAL_TRIALS study record update · 2023-03-21
PANCREATIC NUTRITIONAL PROGRAM (PNP): A Novel Weight Reduction Program in Overweight/Obese Breast Cancer Survivors
CLINICAL_TRIALS study record update · 2023-03-10
Phase II Trial of Neoadjuvant Chemotherapy With Carboplatin and NAB-Paclitaxel in Patients With Locally Advanced and Inflammatory Triple Negative Breast Cancer
CLINICAL_TRIALS study record update · 2023-03-09
Use of 64Cu-DOTA-Trastuzumab PET Imaging and Molecular Markers for Prediction of Response to Trastuzumab and Pertuzum-Based Neoadjuvant Therapy
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2023-02-27
Prevention of Aromatase Inhibitor-Induced Joint Symptoms With Omega 3 Fatty Acid Supplementation: a Randomized Placebo Controlled Pilot Study
CLINICAL_TRIALS study record update · 2022-10-20
A Pragmatic Trial to Evaluate a Guideline-Based Colony Stimulating Factor Standing Order Intervention and to Determine the Effectiveness of Colony Stimulating Factor Use as a Prophylaxis for Patients Receiving Chemotherapy With Intermediate Risk for Febrile Neutropenia - Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER)
CLINICAL_TRIALS study record update · 2022-10-19
A Phase 1B Dose Escalation Trial of Human Anti 4 1BB Agonistic Antibody Utomilumab (PF 05082566) in Combination With Ado Trastuzumab Emtansine or Trastuzumab in Patients With HER2 Postive Advanced Breast Cancer
CLINICAL_TRIALS study record update · 2022-10-05
A Randomized Phase III Post-operative Trial of Platinum Based Chemotherapy vs. Capecitabine in Patients With Residual Triple-Negative Basal-Like Breast Cancer Following Neoadjuvant Chemotherapy
CLINICAL_TRIALS study record update · 2022-09-26
A Phase Ib Trial Evaluating the Safety of Copanlisib, Letrozole, and Palbociclib in Metastatic Breast Cancer and Phase II Trial Comparing the Molecular Effects of Neoadjuvant Copanlisib in Combination With Palbociclib and Letrozole, vs. Copanlisib With Letrozole, vs. Palbociclib With Letrozole for Patients With Hormone Receptor Positive, HER2 Normal Breast Cancer
CLINICAL_TRIALS study record update · 2022-07-27
Impact of Affect Reactivity and Regulation on Breast Cancer Treatment Decisions
CLINICAL_TRIALS study record update · 2022-07-21
Improving Outcomes for Younger Breast Cancer Survivors: A Phase III Randomized Trial Targeting Behavioral Symptoms in Younger Breast Cancer Survivors
CLINICAL_TRIALS study record update · 2022-04-05
Phase II Study of Everolimus Beyond Progression in Postmenopausal Women With Advanced, Hormone Receptor Positive Breast Cancer
CLINICAL_TRIALS study record update · 2022-03-10
A Cardiac Rehabilitation Program for Breast Cancer Survivors: A Feasibility Study
CLINICAL_TRIALS study record update · 2021-12-28
A Multicenter Phase II Study of Docosahexaenoic Acid (DHA) in Patients With a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease
CLINICAL_TRIALS study record update · 2021-11-19
Light-Scattering Spectroscopy for the Detection of Stage II-III Breast Cancer: A Pilot Study
CLINICAL_TRIALS study record update · 2021-08-11
BRE 17107: A Phase Ib/II Trial of Atezolizumab (an Anti-PD-L1 Monoclonal Antibody) With Cobimetinib (a MEK1/2 Inhibitor) or Idasanutlin (an MDM2 Antagonist) in Metastatic ER+ Breast Cancer
CLINICAL_TRIALS study record update · 2021-04-08
Couple-Focused ACT Intervention for Couples Coping With Cancer: A Pilot Study
CLINICAL_TRIALS study record update · 2021-04-05
High-Intensity Interval Training (HIT) for Breast Cancer Patients During Trastuzumab Use
CLINICAL_TRIALS study record update · 2020-09-24
A Phase I-II Study of PTX-200 Plus Sequential Weekly Paclitaxel Followed by Dose-Dense Doxorubicin and Cyclophosphamide in Patients With Metastatic and Locally Advanced Breast Cancer
CLINICAL_TRIALS study record update · 2020-09-21
Phase II Randomized Trial of Mugard Compared With Best Supportive Care for Prevention and Treatment of Stomatitis in Women With Hormone Receptor Positive Breast Cancer Initiating Treatment With Everolimus-based Endocrine Therapy.
CLINICAL_TRIALS study record update · 2020-07-13
Phase II Study of Pembrolizumab and Capecitabine for Advanced Triple Negative and Hormone-Refractory Breast Cancer
CLINICAL_TRIALS study record update · 2020-04-08
Acupuncture and Aromatase Inhibitor Related Arthralgia
CLINICAL_TRIALS study record update · 2020-03-04
A Phase I Study of BYL719 and Trastuzumab-MCC-DM1 in HER2-Positive Metastatic Breast Cancer Patients With Progression on Prior Trastuzumab and Taxane-Based Therapy
CLINICAL_TRIALS study record update · 2020-02-12
Phase II Study of a HER-2/Neu (HER2) Intracellular Domain (ICD) Peptide-Based Vaccine Administered to Patients With Locally Advanced or Stage IV HER2 Positive Breast Cancer